Tacrolimus-induced hyperpigmentation in a patch of vitiligo.
A 10-year-old boy had vitiligo vulgaris involving limited areas and was prescribed topical tacrolimus ointment (0.03%), as the lesions were present in the infraorbital area in addition to other areas including the arms, thighs, and around the knees and ankles. Within 2 months of starting treatment, he had evidence of diffuse repigmentation of all the patches of vitiligo. Two months later, all the lesions repigmented completely with excellent color matching except those in the infraorbital area. The parents were anxious due to brownish hyperpigmentation in the previous patch of vitiligo in infraorbital area (Figure). He had no irritation or burning sensation in the areas of application. There was no history of photosensitivity. The patient was applying tacrolimus once at night, and no photoprotection was advised. Due to location of the lesion in the infraorbital area, a cosmetically important site, the parents did not consent for punch biopsy. The hyperpigmentation was temporary, with reappearance of depigmentation within 1 month of discontinuing topical tacrolimus application.
De
Dipankar
D
Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kanwar
Amrinder Jit
AJ
D000287:Administration, Topical; D002648:Child; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D009824:Ointments; D012880:Skin Pigmentation / Q000187:drug effects*; D016559:Tacrolimus / Q000008:administration & dosage*; D014820:Vitiligo / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D009824:Ointments; D016559:Tacrolimus